trastuzumab deruxtecan 100 mg / vial
An antibody-drug conjugate (ADC) consisting of a HER2-directed monoclonal antibody linked to a topoisomerase I inhibitor (deruxtecan). It targets HER2-expressing cells and releases the chemotherapy directly inside the cancer cell.
Click to expand
Anti Cancer Injection
trastuzumab deruxtecan 100 mg / vial
By ASTRAZENECA
Our Price
₹141,000WHO-GMP
ISO Certified
Trusted Exporter
Secure Supply
Strength
100 mg / vial
Packaging
Single-dose pack containing 1 vial.
Type
Glass Vial packed in a cardboard box.
Shelf Life
24 to 36 months.
An antibody-drug conjugate (ADC) consisting of a HER2-directed monoclonal antibody linked to a topoisomerase I inhibitor (deruxtecan). It targets HER2-expressing cells and releases the chemotherapy directly inside the cancer cell.
Manufacturer Info
NameASTRAZENECA
PrescriptionPrescription
Global Compliance
Our products strictly adhere to International Safety Protocols. 2M Pharmaceuticals ensures 100% genuine supply chain monitoring for all export orders.
TRASTUZUMAB DERUXTECAN 100 mg / vial
₹141,000